These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 30896263

  • 1. Immunostaining characteristics of irisin in benign and malignant renal cancers.
    Kuloğlu T, Artaş G, Yardim M, Sahin I, Aydin Y, Beyoğlu N, Özercan IH, Yalcin MH, Ugur K, Aydin S.
    Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263
    [Abstract] [Full Text] [Related]

  • 2. A promising biomarker to distinguish benign and malignant renal tumors: ELABELA.
    Artas G, Kuloglu T, Dagli AF, Ugur K, Yardim M, Aydin S, Artas H, Kocdor H.
    Niger J Clin Pract; 2019 Mar; 22(3):386-392. PubMed ID: 30837428
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules.
    Iakymenko OA, Delma KS, Jorda M, Kryvenko ON.
    Int J Surg Pathol; 2021 Sep; 29(6):600-605. PubMed ID: 33764165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS.
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC, Chen PC, Ho DM.
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
    Kuroda N, Kanomata N, Yamaguchi T, Imamura Y, Ohe C, Sakaida N, Hes O, Michal M, Shuin T, Lee GH.
    Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
    [Abstract] [Full Text] [Related]

  • 12. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD, Kim KS, Ryu S, Park Y, Cho NH, Rha SH, Jang JJ, Ro JY, Juhng SW, Choi C.
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [Abstract] [Full Text] [Related]

  • 13. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT, Tu JJ, Kao J, Zhou XK, Mazumdar M.
    Clin Cancer Res; 2005 Sep 15; 11(18):6558-66. PubMed ID: 16166433
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
    Jacob JM, Williamson SR, Gondim DD, Leese JA, Terry C, Grignon DJ, Boris RS.
    Urology; 2015 Nov 15; 86(5):956-61. PubMed ID: 26126697
    [Abstract] [Full Text] [Related]

  • 15. Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification.
    Brunelli M, Erdini F, Cima L, Eccher A, Fioravanzo A, Gobbo S, Segala D, Ghimenton C, Mazzoleni G, Munari E, Carella R, Martignoni G.
    Appl Immunohistochem Mol Morphol; 2018 Nov 15; 26(5):316-323. PubMed ID: 27556823
    [Abstract] [Full Text] [Related]

  • 16. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.
    McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR.
    Head Neck Pathol; 2007 Dec 15; 1(2):123-31. PubMed ID: 20614263
    [Abstract] [Full Text] [Related]

  • 17. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
    Jain S, Roy S, Amin M, Acquafondata M, Yin M, Laframboise W, Bastacky S, Pantanowitz L, Dhir R, Parwani A.
    Am J Surg Pathol; 2013 Dec 15; 37(12):1824-30. PubMed ID: 24225843
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
    Wang HY, Mills SE.
    Am J Surg Pathol; 2005 May 15; 29(5):640-6. PubMed ID: 15832088
    [Abstract] [Full Text] [Related]

  • 20. Primary collision tumors of the kidney composed of oncocytoma and papillary renal cell carcinoma: A review.
    McCroskey Z, Sim SJ, Selzman AA, Ayala AG, Ro JY.
    Ann Diagn Pathol; 2017 Aug 15; 29():32-36. PubMed ID: 28807339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.